{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:16:49Z","timestamp":1791191809082,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011117","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T00:00:00Z","timestamp":1462752000000}}],"reference-count":104,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011117.pub2","type":"journal-article","created":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T07:22:00Z","timestamp":1462778520000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Opioid agonist treatment for pharmaceutical opioid dependent people"],"prefix":"10.1002","author":[{"given":"Suzanne","family":"Nielsen","sequence":"first","affiliation":[{"name":"UNSW; National Drug and Alcohol Research Centre; Building R3 22 - 32 King Street Randwick NSW Australia 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briony","family":"Larance","sequence":"additional","affiliation":[{"name":"UNSW; National Drug and Alcohol Research Centre; Building R3 22 - 32 King Street Randwick NSW Australia 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[{"name":"UNSW; National Drug and Alcohol Research Centre; Building R3 22 - 32 King Street Randwick NSW Australia 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Gowing","sequence":"additional","affiliation":[{"name":"University of Adelaide; Discipline of Pharmacology; Frome Road Adelaide South Australia Australia 5005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyanne","family":"Kehler","sequence":"additional","affiliation":[{"name":"UNSW; National Drug and Alcohol Research Centre; Building R3 22 - 32 King Street Randwick NSW Australia 2031"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lintzeris","sequence":"additional","affiliation":[{"name":"South Eastern Sydney Local Health District; Drug and Alcohol Services; The Langton Centre 591 South Dowling St Surry Hills NSW Australia 2010"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,9]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0002|cit1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02915283","article-title":"Controlled trial of maintenance treatment of intravenous buprenorphine dependence","volume":"172","author":"Ahmadi","year":"2005","journal-title":"Irish Journal of Medical Science"},{"issue":"9","key":"10.1002\/14651858.CD011117.pub2-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2362.2003.01218.x","article-title":"Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study","volume":"33","author":"Ahmadi","year":"2003","journal-title":"English Journal of Clinical Investigation"},{"issue":"16","key":"10.1002\/14651858.CD011117.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D'Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD011117.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper v maintenance therapy for prescription opioid dependence","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011117.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/10550887.2012.759872","article-title":"A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction","volume":"32","author":"Neumann","year":"2013","journal-title":"Journal of Addictive Diseases"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2012.08.002","article-title":"Buprenorphine\/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial","volume":"128","author":"Saxon","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"17","key":"10.1002\/14651858.CD011117.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD011117.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1300\/J069v13n03_04","article-title":"A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification","volume":"13","author":"Amass","year":"1994","journal-title":"Journal of Addictive Diseases"},{"issue":"9","key":"10.1002\/14651858.CD011117.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1360-0443.2007.01935.x","article-title":"Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status","volume":"102","author":"Anglin","year":"2007","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD011117.pub2-BIB0010|cit10","first-page":"138","article-title":"A controlled trial of methadone treatment: preliminary analysis of effects on medical care utilization","volume":"17","author":"Batki","year":"1998","journal-title":"Journal of Addictive Diseases"},{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1211\/ijpp.14.4.0003","article-title":"Pilot randomised controlled trial of community pharmacy administration of buprenorphine versus methadone","volume":"14","author":"Cameron","year":"2006","journal-title":"International Journal of Pharmacy Practice"},{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1037\/a0016597","article-title":"Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine","volume":"17","author":"Chopra","year":"2009","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011117.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000052034","article-title":"Comparison of buprenorphine and methadone maintenance in opiate addicts","volume":"4","author":"Eder","year":"1998","journal-title":"European Addiction Research"},{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011117.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1360-0443.1999.94913376.x","article-title":"Buprenorphine versus methadone maintenance for the treatment of opioid dependence","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"issue":"9","key":"10.1002\/14651858.CD011117.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s001150050514","article-title":"Buprenorphine vs methadone maintenance treatment for opioid dependence","volume":"70","author":"Fischer","year":"1999","journal-title":"Nervenarzt"},{"issue":"10","key":"10.1002\/14651858.CD011117.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011117.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0376-8716(00)00211-8","article-title":"Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study","volume":"62","author":"Gossop","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2007.11.021","article-title":"A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification","volume":"94","author":"Gruber","year":"2008","journal-title":"Drug and alcohol dependence"},{"issue":"5","key":"10.1002\/14651858.CD011117.pub2-BIB0020|cit20","first-page":"147","article-title":"Better efficacy of buprenorphine and methadone in opioid dependence. Requirements for abstinence from non-opioids before starting treatment paid off","volume":"111","author":"Hoffmann","year":"2014","journal-title":"Lakartidningen"},{"issue":"20","key":"10.1002\/14651858.CD011117.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD011117.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug and Alcohol Dependence."},{"issue":"18","key":"10.1002\/14651858.CD011117.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/1064-1297.13.4.293","article-title":"Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence","volume":"13","author":"Marsch","year":"2005","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"9358","key":"10.1002\/14651858.CD011117.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD011117.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3109\/10826088209056328","article-title":"Evaluation of clinic attendance schedules for LAAM and methadone: a controlled study","volume":"17","author":"Karp-Gelernter","year":"1982","journal-title":"International Journal of the Addictions"},{"issue":"2","key":"10.1002\/14651858.CD011117.pub2-BIB0027|cit27","first-page":"148","article-title":"Buprenorphine and methadone to opiate addicts - a randomized trial","volume":"125","author":"Kristensen","year":"2005","journal-title":"Tidsskrift for den Norske laegeforening"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0028|cit28","first-page":"S108","article-title":"Initiating buprenorphine maintenance for opiate-dependent hospitalized patients: a randomized controlled trial","volume":"28","author":"Liebschutz","year":"2013","journal-title":"Journal of General Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011117.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archpsyc.1996.01830050035005","article-title":"A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence","volume":"53","author":"Ling","year":"1996","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0031|cit31","first-page":"S266","article-title":"Buprenorphine implants for the treatment of opioid dependence: six and 12 month outcomes","volume":"38","author":"Beebe","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jama.2010.1427","article-title":"Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial","volume":"304","author":"Ling","year":"2010","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD011117.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1360-0443.2005.01122.x","article-title":"Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use","volume":"100","author":"Longshore","year":"2005","journal-title":"Addiction"},{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0034|cit34","first-page":"212","article-title":"Buprenorphine vs methadone: an Italian multicenter study","volume":"13","author":"Maremmani","year":"1999","journal-title":"Giornale Italiano di Farmacia Clinica"},{"issue":"1","key":"10.1002\/14651858.CD011117.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/08897077.2011.609446","article-title":"A randomized trial of methadone initiation prior to release from incarceration","volume":"33","author":"McKenzie","year":"2012","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1002\/14651858.CD011117.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clpt.2003.09.004","article-title":"Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence","volume":"75","author":"Montoya","year":"2004","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD011117.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00163-0","article-title":"Double-blind randomized trial of buprenorphine and methadone in opiate dependence","volume":"62","author":"Petitjean","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2014.10.003","article-title":"Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia","volume":"50","author":"Piralishvili","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1002\/14651858.CD011117.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1360-0443.2011.03463.x","article-title":"Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial","volume":"106","author":"Reimer","year":"2011","journal-title":"Addiction"},{"issue":"12","key":"10.1002\/14651858.CD011117.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/j.1360-0443.2006.01603.x","article-title":"Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: a randomized controlled trial","volume":"101","author":"Robertson","year":"2006","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/add.12315","article-title":"Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine\/naloxone","volume":"108","author":"Rosenthal","year":"2013","journal-title":"Addiction"},{"issue":"10","key":"10.1002\/14651858.CD011117.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0043|cit43","first-page":"202","article-title":"Attrition from a randomized trial comparing psychosocial treatments in a 180-day methadone detoxification clinic","volume":"132","author":"Sees","year":"1993","journal-title":"NIDA Research Monograph Series"},{"issue":"12","key":"10.1002\/14651858.CD011117.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamapsychiatry.2013.2216","article-title":"A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers","volume":"70","author":"Sigmon","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011117.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0376-8716(83)90068-6","article-title":"Treatment outcome in methadone detoxification: relationship to initial levels of illicit opiate use","volume":"12","author":"Stitzer","year":"1983","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD011117.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004714-199602000-00010","article-title":"Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index","volume":"16","author":"Strain","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD011117.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1046\/j.1360-0443.2000.951116314.x","article-title":"Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome","volume":"95","author":"Strang","year":"2000","journal-title":"Addiction"},{"issue":"10","key":"10.1002\/14651858.CD011117.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/archinte.1982.00340230087016","article-title":"Outpatient treatment of prescription opioid dependence: comparison of two methods","volume":"142","author":"Tennant","year":"1982","journal-title":"Archives of Internal Medicine"},{"issue":"S1","key":"10.1002\/14651858.CD011117.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000052036","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study","volume":"4","author":"Uehlinger","year":"1998","journal-title":"European Addiction Research"},{"issue":"12","key":"10.1002\/14651858.CD011117.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence","volume":"68","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD011117.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0376-8716(99)00074-5","article-title":"Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet","volume":"58","author":"Amass","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1002\/14651858.CD011117.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.285.1.39","article-title":"Deaths attributable to methadone vs buprenorphine in France","volume":"285","author":"Auriacombe","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1360-0443.2009.02538.x","article-title":"Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users","volume":"104","author":"Banta-Green","year":"2009","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2003.10.012","article-title":"Prescription opioid abuse in patients presenting for methadone maintenance treatment","volume":"73","author":"Brands","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD011117.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10826089609045806","article-title":"Methadone maintenance and addicts' risk of fatal heroin overdose","volume":"31","author":"Caplehorn","year":"1996","journal-title":"Substance Use & Misuse"},{"issue":"5","key":"10.1002\/14651858.CD011117.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337028","article-title":"Misuse of medicines in the European Union: a systematic review of the literature","volume":"18","author":"Casati","year":"2012","journal-title":"European Addiction Research"},{"issue":"2","key":"10.1002\/14651858.CD011117.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002210","article-title":"LAAM maintenance vs methadone maintenance for heroin dependence","author":"Clark","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0059|cit59","doi-asserted-by":"crossref","unstructured":"Cleeland C The Brief Pain Inventory (BPI) 1991","DOI":"10.1037\/t04175-000"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2015.04.003","article-title":"Prescription opioid abuse: problems and responses","volume":"80","author":"Compton","year":"2015","journal-title":"Preventive Medicine"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0061|cit61","unstructured":"Degenhardt L Larance B Mathers B Azim T Kamarulzaman A Mattick R Reference Group to the United Nations on HIV and Injecting Drug Use Benefits and risks of pharmaceutical opioids: essential treatment and diverted medication. A global review of availability, extra-medical use, injection and the association with HIV National Drug and Alcohol Research Centre, University of New South Wales 2007"},{"issue":"1-2","key":"10.1002\/14651858.CD011117.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD011117.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD011117.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/09595230801956124","article-title":"Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users","volume":"27","author":"Fischer","year":"2008","journal-title":"Drug and Alcohol Review"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD011117.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"ES191","DOI":"10.36076\/ppj.2012\/15\/ES191","article-title":"Prescription opioid related misuse, harms, diversion and interventions in Canada: a review","volume":"15","author":"Fischer","year":"2012","journal-title":"Pain Physician"},{"issue":"5","key":"10.1002\/14651858.CD011117.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5694\/j.1326-5377.2010.tb03911.x","article-title":"Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases","volume":"193","author":"Frei","year":"2010","journal-title":"Medical Journal of Australia"},{"issue":"8","key":"10.1002\/14651858.CD011117.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004145.pub4","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"e6425","DOI":"10.1136\/bmj.e6425","article-title":"The role of opioid substitution treatment in reducing HIV transmission","volume":"345","author":"Gowing","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2471\/BLT.12.109553","article-title":"Mitigating the risk of HIV infection with opioid substitution treatment","volume":"91","author":"Gowing","year":"2013","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"The GRADE working group","year":"2004","journal-title":"BMJ"},{"issue":"2-3","key":"10.1002\/14651858.CD011117.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2011.04.004","article-title":"30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California","volume":"118","author":"Grella","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"7560","key":"10.1002\/14651858.CD011117.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0075|cit75","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD011117.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","article-title":"A 33-year follow-up of narcotics addicts","volume":"58","author":"Hser","year":"2001","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1017\/S0033291702006074","article-title":"Short screening scales to monitor population prevalences and trends in non-specific psychological distress","volume":"32","author":"Kessler","year":"2002","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0078|cit78","volume-title":"Manual for Depression and Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0079|cit79","first-page":"E671","article-title":"Prevalence of pain among non-medical prescription opioid users in substance use treatment populations: systematic review and meta-analyses","volume":"16","author":"Lusted","year":"2013","journal-title":"Pain Physician"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0080|cit80","first-page":"e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD011117.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"issue":"3","key":"10.1002\/14651858.CD011117.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011117.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/10826084.2013.800112","article-title":"Engagement, retention, and abstinence for three types of opioid users in Florida","volume":"48","author":"McCabe","year":"2013","journal-title":"Substance Use & Misuse"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients","volume":"22","author":"Moore","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5055\/jom.2011.0077","article-title":"Characteristics of a non-treatment seeking sample of over-the-counter codeine users: implications for intervention and prevention","volume":"7","author":"Nielsen","year":"2011","journal-title":"Journal of Opioid Management"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/ADM.0b013e318277e92e","article-title":"A comparison of buprenorphine taper outcomes between prescription opioid and heroin users","volume":"7","author":"Nielsen","year":"2013","journal-title":"Journal of Addiction Medicine"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.drugalcdep.2015.02.004","article-title":"Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011","volume":"149","author":"Nielsen","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jsat.2014.06.006","article-title":"Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users","volume":"48","author":"Nielsen","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0091|cit91","unstructured":"Substance Abuse and Mental Health Services Administration Results from the 2011 national survey on drug use and health: summary of national findings 2012"},{"issue":"3","key":"10.1002\/14651858.CD011117.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/medicina43030029","article-title":"Outpatient methadone maintenance treatment program. Quality of life and health of opioid-dependent persons in Lithuania","volume":"43","author":"Padaiga","year":"2007","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0093|cit93","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/ip.2010.029611","article-title":"Increasing deaths involving oxycodone, Victoria, Australia, 2000-09","volume":"17","author":"Rintoul","year":"2010","journal-title":"Injury Prevention"},{"issue":"5","key":"10.1002\/14651858.CD011117.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5694\/mja10.11450","article-title":"Prescription of opioid analgesics and related harms in Australia","volume":"195","author":"Roxburgh","year":"2011","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.pain.2008.06.025","article-title":"Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials","volume":"139","author":"Turk","year":"2008","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0097|cit97","unstructured":"United Nations Office on Drugs and Crime World Drug Report Vienna UNODC"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187447370801150611184218","article-title":"The misuse of prescription opioids: a threat for Europe?","volume":"8","author":"Amsterdam","year":"2015","journal-title":"Current Drug Abuse Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011117.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"4","key":"10.1002\/14651858.CD011117.pub2-BIB0101|cit101","first-page":"280","article-title":"Medical management of opioid dependence in South Africa","volume":"98","author":"Weich","year":"2008","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2015.01.027","article-title":"Trends in abuse and misuse of prescription opioids among older adults","volume":"149","author":"West","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0103|cit103","volume-title":"WHOQOL: Measuring Quality of Life","author":"World Health Organization","year":"1997"},{"key":"10.1002\/14651858.CD011117.pub2-BIB0104|cit104","volume-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"World Health Organization","year":"2009"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011117.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011117.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T15:01:28Z","timestamp":1655737288000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011117.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,9]]},"references-count":104,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011117.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,9]]}}}